{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Carbon Nanotubes in Cancer Treatment"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to receive either CNT-based treatment or standard care."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients diagnosed with PC, LC, GC, CRC, or RC. The trial was conducted in a clinical setting."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to receive either CNT-based treatment or standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "To assess the effectiveness of CNTs in improving treatment outcomes for PC, LC, GC, CRC, and RC."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the improvement in survival rate over a 5-year period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised, with 100 in the CNT group and 100 in the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the CNT group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The CNT group showed a significant improvement in survival rate (mean difference = 5.2%, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the CNT group and 1% in the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01773850."
      },
      "Funding": {
        "score": 0,
        "evidence": "The trial was funded by [source not specified]."
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}